Nasal spray for dry eye disease and tear film stability
Treatments studied
Part of Eyes & vision, Injuries & trauma clinical trials.
This study tests whether a nasal spray can improve dry eye symptoms and tear production in people with mild to moderate meibomian gland dysfunction (a common cause of dry eye). You'll use the spray daily while the research team monitors your eye health and comfort over several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older with the ability to consent to participate
- Moderate dry eye symptoms (OSDI score above 13) and mild to moderate meibomian gland dysfunction (blocked oil glands in the eyelids)
- Vision of 20/40 or better with glasses or contacts
- Willing to stop all prescription dry eye medications and eye drops during the study, but continue warm compresses or eyelid cleaning if you use them
- No active eye infections, severe eyelid inflammation, or recent eye surgery (within 3–12 months depending on surgery type)
- No chronic sinus problems, nosebleeds, or bleeding disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal spray (varenicline) to see if it can relieve discomfort and dryness from contact lens wear. If you wear daily disposable soft contacts and experience end-of-day eye dryness, you may be eligible.
This trial tests a food supplement designed to improve dry eye symptoms by targeting the microbiome. It may help if you have dry eye due to meibomian gland problems and are not using contact lenses or certain other eye treatments.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
This trial tests a virtual reality headset (called Lacrima VR) to see if it can help relieve dry eye symptoms caused by meibomian gland dysfunction. It might be a non-drug option for people who have not found relief from other treatments.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
This trial tests a new type of eye drop (called VMX) to see if it helps people with mild to moderate dry eye. The study will compare how well the eye drops work and if they are safe for you to use.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.